Cochrane · systematic review · CD002948
Herbal therapy for treating rheumatoid arthritis
Cameron, M, Gagnier, JJ, Chrubasik, S · Cochrane Database of Systematic Reviews · 2011 · Cochrane Library
MusculoskeletalAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
12
current version
GRADE rated
5
No studies
7
Included studies
NR
No studies 7 · 58.3%Ungraded 0 · 0%Very low 0 · 0%Low 3 · 25%Moderate 2 · 16.7%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Questions and results
Comparison
Population: patients with treating rheumatoid arthritis
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
ACR 50% improvement ‐ not measured | no estimate extracted | NR | No studies |
Pain Visual Analogue Scale. Scale from: 0 to 100. ( | no estimate extracted | 3 studies · 82 participants | Moderate Downgraded: risk of bias |
Disability (HAQ score) percent change. Scale from: 0 to 100. ( | no estimate extracted | 1 study · 41 participants | Low Downgraded: risk of bias |
Participants (n) reported adverse events ( | RR 4.24 [0.78, 22.99] | 2 studies · 61 participants | Moderate Downgraded: risk of bias |
Change in radiographic progression ‐ not measured | no estimate extracted | NR | No studies |
Achievement of low disease state (DAS 28) ‐ not measured | no estimate extracted | NR | No studies |
Comparison
Population: patients with Rheumatoid arthritis
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
ACR 50% improvement ( | RR 11.92 [0.73, 193.38] | 1 study · 23 participants | Low Downgraded: imprecision |
Change in pain ‐ not measured | no estimate extracted | NR | No studies |
HAQ disability score ‐ not measured | no estimate extracted | NR | No studies |
Participants (n) reported adverse events ( | RR 1.36 [0.49, 3.82] | 1 study · 23 participants | Low Downgraded: imprecision |
Change in radiographic progression ‐ not measured | no estimate extracted | NR | No studies |
Achievement of low disease state (DAS 28) ‐ not measured | no estimate extracted | NR | No studies |